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Summary 
A cDNA clone complementary to an interferon (IFN)-induced mRNA approximately 3 kb in 
length was identified and sequenced revealing homology with the endoplasmic reticular heat 
shock protein/ATPase gp96. Both IFN-cx and -3' transcriptionally upregulate expression of this 
gene. gp96 transcripts,  protein,  and ATPase activity are shown to be enhanced as a result of 
IFN treatment in two human cell lines and this effect requires de novo protein synthesis, gp96 
molecules have recently been implicated in the presentation of endogenous antigens. A number 
of the key elements in this pathway, the transporter proteins, the major histocompatibility complex 
(MHC)-linked units of the proteasomes and the MHC class I molecules are known to be IFN 
inducible. Our results show that yet another molecule suggested to play an accessory role in 
the endogenous presentation pathway is IFN inducible. Further, our studies represent the first 
demonstration of modulation of expression of a heat shock protein by a cytokine and identify 
a new enzymatic activity upregulated in IFN-treated cells. 
T 
he IFNs are a family of regulatory molecules which, after 
binding to cell surface receptors of responsive cells, are 
capable of mediating an antiviral state,  an antiproliferative 
effect, and a variety of immune responses (1-5). The estab- 
lishment of an antiviral effect by the IFNs has been shown 
to require de novo synthesis of cellular mRNAs and proteins 
(6-8). Much recent research on the mechanism of action of 
the IFNs has focused on the induction of genes and protein 
products in response to IFN treatment. To date, IFN treat- 
ment has been shown to result in elevated levels of several 
new mRNAs, proteins and at least four enzyme activities, 
2',5'-oligoadenylate synthetase, protein kinase,  indoleamine 
2',Y-dioxygenase, and tryptophanyl tRNA synthetase (1, 2, 
4,  5,  9,  10). We report here that IFN treatment results in 
transcriptional upregulation of a constitutively expressed heat 
shock protein (hsp) gp96 (11), which is also an ATPase (12). 
These studies represent the first example of IFN-induced 
modulation of a hsp and identify a new IFN-induced enzyme 
activity. Further, the gp96 hsp has recently been implicated 
in presentation of endogenous antigens by MHC class I mol- 
ecules (12, 13). A number of the key elements in this pathway, 
the transporter proteins, the MHC-linked units of the pro- 
teasomes and the MHC class I molecules are known to be 
IFN inducible. Our results show that yet another molecule 
suggested to play an accessory role in the endogenous pre- 
sentation pathway is IFN inducible. 
The first two authors contributed equally to this work. 
Materials  and Methods 
Cell Lines.  The Dandi and HeLa cell lines were obtained from 
the American Type Culture Collection (Rockville, MD). Daudi 
cells were maintained in RPMI 1640 (GIBCO BRL, Gaithersburg, 
MD) and HeLa ceLls were maintained in minimal essential media 
(MEM) (GIBCO BILL). All media was supplemented with 10% 
FCS and 100/~g/mL  penicillin and streptomycin. 
IFN.  Natural human IFN-a (specific  activity, >108 IU/mg of 
protein) was purified using an NK-2 monodonal antibody column 
(CeUtech, Slough, UK). Purified recombinant IFNw was purchased 
from Amgen Biologicals (Thousand Oaks, CA). All IFN values 
are expressed in international reference units  (IU). 
Constmca'on of  a eDNA Library.  mRNA was isolated from Dandi 
cells using the FastTrack mRNA isolation kit (Invitrogen,  San 
Diego, CA) and used to construct  a hgtl0 recombinant cDNA 
library essentially as described (14, 15). 
Synthesis of 3:P-labeled  Single-stranded cDNA Probes.  32p-labeled 
single-stranded cDNA probes were generated from mRNA of un- 
treated Daudi calls and Dandi cells treated with IFN-a for 18 h 
as described (16). 
Differential Screening of the eDNA Library.  The Xgtl0 library 
was screened with the 3Zp-labded single-stranded cDNA probes 
generated from mRNA isohted from untreated and IFN-treated 
Daudi cells as described (16). 
Northern Blot Analysis.  Poly (A §  RNA isolated as described 
above was run on denaturing agarose  gels, transferred  to nylon mem- 
branes, and hybridized as described (16). Where indicated, hybrid- 
ization signals were quantitated with a pdi scanning system (pdi, 
Huntington Station,  NY).  For all data presented,  the relative 
amounts of mRNA loaded for each sample were determined by 
measuring the signal generated with a radiolabeled 770-bp actin 
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values presented  have  been standardized  against actin mRNA, whose 
levels have  been observed to be unaffected  by IFN treatment under 
the conditions tested. 
Isolation of eDNA Inserts and Preparation of eDNA Probes.  Insert 
DNA from the gp96 hgtl0 clone was isolated as described (16). 
hsp70 cDNA was a kind gift of  Dr. J. Thomas (New York Univer- 
sity, NY). cDNA was radiolabeled as described (16, 17). 
Plasraid Construction and DNA Sequencing.  cDNA isolated  from 
Xgtl0. as described above was subcloned into the EcoRI site of 
pGEM-3Z (Promega Corp.,  Madison, WI), propagated and se- 
quenced as described (9,  18). 
Measurement of Transcription Rate.  Nuclear  run-on assays were 
performed as described (19, 20). Hybridization to the cDNA in- 
sert and quantitation of  bound radiolabeled  RNA were as described 
(9). As controls, the radiolabeled RNA samples were also hybrid- 
ized to nitrocellulose strips to which 200 ng of a 770 base pair 
cDNA recognizing actin (Oncor, Inc.) or a 1.8-kb cDNA insert 
encoding the IFN-induced tryptophanyl tKNA synthetase (WRS) 
was bound. The IFN treatment did not affect  the amount of actin- 
specific mRNA produced by these nuclei. 
ATPase Assay.  107 Daudi cells incubated for 18  h with or 
without 300 IU/mL IFN-c~ were harvested, washed three times 
with PBS, then dounced in 0.5 mL 20 mM Hepes, pH 7.2, 20 
mM NaCI, and 2 mM MgCh. After centrifugation at 1,000 g for 
5 min, the supernatant was harvested and centrifuged at 10,000 
2 for 10 min. 250 gg of the resulting supernatant were assayed 
for ATPase activity by the method of Flynn et al. (21). 5 #L were 
then spotted onto a precoated polyethyleneimine (PEI) cellulose 
plate (Sigma, Chemical Co., St. Louis, MO) and chromatography 
was performed for 3 h against a 1:1 ratio of I M LiC1 and 1 M 
HCOOH. The plate was dried and autoradiographed. 
Antibody Neu~lization Studies.  Before  being added to the ATPase 
assay, 250 ng of cell extract were incubated with or without I gg 
of a rat anti-gp96 monoclonal antibody (Stressgen, Victoria, BC, 
Canada) or 1 gg of normal rat IgG (Accurate  Chemical  and Scientific 
Corp., Westbury, NY) for 1 h at room temperature. 
Immunoprecipitations.  Daudi cells (5  x  10  s cells/mL) were la- 
beled for 18 h with [3SS]methionine  in KPMI containing 1/5 the 
usual methionine concentration in the presence or absence of 300 
IU/mL IFN-c~. Extracts were prepared and immunoprecipitations 
were performed as described (22). 
Results 
Isolation of a eDNA  Clone Encoding gp96.  A cDNA li- 
brary constructed in )xgtl0 from Poly (A +) mRNA isolated 
from Daudi cells was screened with radiolabeled cDNA pre- 
pared from mRNA of untreated or IFN-ol-treated Daudi cells. 
A clone, Xlx-1, was observed to generate a stronger signal 
when probed with cDNA prepared  from mRNA of IFN- 
ol-treated Daudi cells than with cDNA prepared from mRNA 
of untreated cells. Comparison of partial nucleotide sequences 
of Xlx-1 cDNA with other sequences present in GenBank 
(23) revealed that it is identical with the human homologue 
of the murine tumor rejection antigen and endoplasmic re- 
ticular hsp gp96  (Fig.  1). 
Analysis of IFN Induction of the mRNA  Encoding gF96. 
Northern blot analysis was performed on mRNA isolated 
from IFN-ol-treated or untreated Dandi cells, employing a 
probe generated from the cDNA of done Xlx-1 and gp96 
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cDNA probe pH48  (11). Both probes showed an identical 
pattern of hybridization. The results reveal that the IFN treat- 
ment of  cells results in an enhanced accumulation of an mRNA 
species of ",~3 kb in length (Fig.  2 A). Quantitation of the 
3-kb transcript showed an IFN-mediated enhancement of ap- 
proximately fourfold. Northern blot analysis  of untreated HeLa 
cells and HeLa cells incubated in the presence of IFN-t~ or 
IFN-~/for 18 h demonstrates a similar IFN-mediated increase 
in accumulation of the 3-kb transcript (Fig. 2 A). An exami- 
nation of the kinetics of accumulation of this RNA in Daudi 
cells after IFN treatment revealed that the level of this RNA 
slowly increases after incubation with IFN (Fig.  2 B). 
To ascertain whether IFN treatment affects the transcription 
or stabilization of the gp96 mRNA, nuclear run-on transcrip- 
tion assays were performed on RNA prepared from IFN- 
treated and untreated Daudi cells. Nuclear RNA from IFN- 
treated or untreated cells was hybridized with cDNA for gp96, 
actin and the IFN-inducible tryptophanyl tRNA synthetase 
(WRS). The data presented in Fig.  2 C reveal a clear IFN- 
mediated elevation in the level of transcription of gp96 gene, 
comparable to the level of induction of the WKS gene. No 
significant differences  are  seen in the actin control. 
To distinguish between the possibilities  that the accumu- 
lation of the gp96 mRNA either occurs as a direct result 
of the IFN treatment or requires prior de novo protein syn- 
thesis,  Daudi cells were incubated with cycloheximide (50 
#g/ml), a protein synthesis inhibitor, for 30 min before and 
8 h after the addition of IFN-cr  and the level of the gp96 
mRNA was determined as described earlier.  No induction 
of the gp96 mRNA was observed in the cells incubated with 
cycloheximide and IFN (Fig.  2 D) demonstrating that the 
IFN-mediated induction of gp96 mRNA is dependent on 
cellular protein synthesis and does not occur as a direct result 
of IFN treatment. 
Lack of Inducibility of hsp70 by IFN.  The known induc- 
ibility of gp96 in response  to stress  (24,  25) prompted us 
to examine whether the IFN-mediated induction of gp96 was 
due to a general stress response by the cells. The effect of 
IFN  on the inducibility of a classical stress-induced  gene, 
hsp70, was therefore examined. Northern blots of IFN-treated 
and untreated Daudi cells were probed with the hsp70 cDNA 
probe and it was observed that IFN treatment failed to mediate 
an induction ofhsp70 mRNA (Fig. 3). It would thus appear 
that the transcriptional upregulation of gp96 is not part of 
a general stress-induced response, but rather is specific to gp96. 
Induction of gp96 Protein by IFN.  Induction of gp96 in 
IFN-treated cells was tested at the protein level. IFN-treated 
and untreated Daudi cells were metabolically labeled with 
[3SS]methionine  and  extracts  prepared  as  described  in 
Materials and Methods. The extracts were immunoprecipi- 
tated with a rat anti-human gp96 monoclonal antibody or 
with unrelated rat immunoglobulins. A clearly enhanced syn- 
thesis of gp96 is observed in the IFN-treated cells (Fig. 4). 
A  number  of nonspecific bands  are  also  seen  in  the im- 
munoprecipitations; it may be noted that the levels of the 
nonspecifically precipitating bands are identical in IFN-treated 
and untreated cells. The only exception to this is an =56-kD 
band, which is present at elevated levels in extracts of IFN- 
Induced by IFN A  NucLeotide  sequence  at  5'  end  of  ALX-1 
AIX-1 
HUNTRAI 
AIX-I 
HLJMTRAI 
AIX-1 
HUHTRAI 
GTGGGCGGAC  CGCGCGGCTG GAGGTGTGAG GATCCGAACC  CAGGGGTGGG  GGGTGGAGGC 
GTGGGCGGAC  CGCGCGGCTG GAGGTGTGAG GATCCGAACC  CAGGGGTGGG  GGGTGGAGGC 
GGCTCCTGCG  ATCGAAGGGG ACTTGAGACT CACCGGCCGC  ACGCCATGAG  GGCCCTGTGG 
::::::::::  ::::::::::  ::::::::::  ::::::::::  ::::::::::  :::::::::: 
GGCTCCTGCG  ATCGAAGGGG ACTTGAGACT CACCGGCCGC  ACGCCATGAG  GGCCCTGTGG 
GTGCTGGGCC  TCTGCTGCGT CCTGCTGACC  T  151 
GTGCTGGGCC  TCTGCTGCGT CCTGCTGACC  T  151 
60 
60 
120 
120 
Hucleotide 
AIX-1 
HUMTRA[ 
AIX-1 
HUHTRAI 
AIx-1 
HUMTRAI 
sequence at  3'  end of  hlX-1 
AATCTCGTCA  AAAAATATTC ACAGTTCATA AACTTTCCTA TTTATGTATG  GAGCAGCAAG 
AATCTCGTCA  AAAAATATTC ACAGTTCATA AACTTTCCTA TTTATGTATG  GAGCAGCAAG 
ACTGAAACTG  TTGAGGAGCC CATGGAGGAA GAAGAAGCAG CCAAAGAAGA GAAAGAAGAA 
::::::::::  ::::::::::  ::::::::::  ::::::::::  ::-*:::::::  :::::::::: 
ACTGAAACTG  TTGAGGAGCC CATGGAGGAA GAAGAAGCAG CCAAAGAAGA GA.,kAGAAP.d~ 
TCTGATGATG  AAGCTGCAGT AGAGC~AGAA  GAAGAAGA  158 
::::::::::  ::::::::::  :::::::1::  :::::::: 
TCTGATGATG  AAGCTGCAGT AGAGGAAGAA  GAAGAAGA  1058 
Figure 1.  The  nucleotide  sequence  of the  lx-1 
cDNA and a comparison with the nudeotide sequence 
96o  of gp96 mRNA (HUMTRAI). The nucleotide se- 
quence of"~150 bases at the 5' end of the lx-1 cDNA 
120  and "~150 bases at the 3' end was determined as de- 
1020  scribed in the Materials and Methods. The optimized 
nucleotide sequence alignment was performed as de- 
scribed (23). The right column numbers refer to the 
last nucleotide in each line. 
Figure 2.  Induction of gp96 mRNA in response 
to IFN treatment. Daudi or HeLa ceils  were incubated 
for 18 h in the presence of no IFN (lanes I  and 3), 
300 IU/mL IFN-~ (lanes 2 and 4), or 300 IU/mL 
IFN-~ (lane 5). Poly (A +) RNA from these cells was 
purified and Northern blot analysis performed as de- 
scribed in the Materials and Methods.  Positions of 
RNA molecuhr weight markers (not shown) run in 
parallel were used to determine the size of the gp96 
mRNA. (B) The kinetics of accumulation of the gp96 
mRNA in response  to IFN treatment. Daudi ceils  were 
incubated for the time periods incubated in the pres- 
ence of no IFN or 300 IU/mL IFN-c~. Poly (A+) 
RNA from these ceils was isolated and purified, then 
Northern blot analysis was performed as described in 
the Materials and Methods. After autoradiography, the 
quantitation  of the signals generated by hybridization 
was  determined  as described in the  Materials  and 
Methods.  The  hybridization  signals  generated  by 
mRNA from IFN-treated cuhures are presented as a 
percentage of the hybridization  signal generated by 
mRNA from untreated cultures. (C) Nuclear run-on 
transcriptional  analysis of  the  IFN-induced gp96 
mRNA in response  to IFN treatment. Dandi cells  were 
incubated for 14 h in the presence of either no IFN 
(con) or 300 IU/mL IFN-~ (IFN). The nuclei were 
isolated and their mKNA isolated as described in the 
Materials and Methods. The RNA was hybridized to 
a membrane spotted with cDNAs for gp96 (1), actin 
(2), and WKS (3). The amount of radioactivity associated with the gp96 cDNA was determined  as described in the Materials and Methods  and is 
presented as a histogram.  (/9) Lack of induction of gp96 mRNA by IFN in the presence of a protein inhibitor. Daudi calls were treated in the absence 
(lanes 1 and 2) or presence (lanes 3 and 4) of cycloheximide and in the absence (lanes I  and 3) or presence (lanes 2  and 4) of IFN-ol as described 
in the text.  Poly (A +) mR.NA  from these ceUs was purified and northern blot analysis performed  as described in the Materials and Methods. 
Figure 3.  Lack of induction of a stress- 
related mRNA in response to IFN-c~. Daudi 
cells were incubated for 18 h in the presence 
(IFN) or absence (-) of 300 IU/mL IFN-ot. 
Poly (A +) RNA from these cells was iso- 
lated, purified, and subjected  to Northern blot 
analysis  using a probe for hsp70 as described 
in the Materials and Methods. 
treated cells. This band is a result of autodegradation of gp96 
as reported  earlier  (22). 
Induction of gp96/ATPase Activity by IFN.  The effect of 
IFN on the cellular level of ATPase  was examined.  Soluble 
extracts from IFN-treated and untreated Daudi cells were pre- 
pared and assayed for total ATPase  activity. A  significantly 
enhanced ATPase activity was observed in IFN-treated cells. 
To determine if this increase was due to gp96, a monodonal 
1567  Anderson et al.  Brief Definitive Report Figure 4.  Induction  of gp96 protein in re- 
sponse to IFN treatment.  Daudi cells were 
incubated with [~sS]methionine for 18 h in 
the absence (-) or presence (IFN) of 300 
IU/mL of  IFN-~. Extracts were prepared and 
immunopredpitatiom pel"i"ormed  as described 
in the Materials and Methods. 
anti-gp96 antibody was included in the assay. It was observed 
(Fig. 5) that the IFN-induced increase in ATPase  activity could 
be neutralized by anti-gp96 antibody. In contrast, unrelated 
rat immunoglobulins  failed to neutralize this ATPase activity. 
Discussion 
IFN treatment of cells has been shown to result in the en- 
hanced synthesis of several proteins and mRNAs (1, 2,  4, 
5). In this report, we show that the major endoplasmic  retic- 
ular protein gp96, which is also a peptide-binding hsp and 
an ATPase (12, 26), belongs to the group of IFN-inducible 
proteins. The enhancement in expression  of g'p96 is medi- 
ated at the transcriptional level and requires de novo protein 
synthesis. Consistent with the ATPase activity of gp96, IFN- 
treated cells show a significantly enhanced ATPase activity 
and a substantial proportion of this increment is neutralized 
by anti-gp96 monodonal antibody. 
In light of the IFN-mediated inducibility of gp96, we ex- 
amined the 5' regulatory region of the gene encoding gp96 
for the presence of elements resembling the IFN-stimulated 
response element (ISRE) observed to be present in the 5' un- 
translated region of many of the IFN-inducible genes. We 
have observed that the sequence located between nucleotides 
-518 and -506 (GTTTCTTCTTTCC), relative to the tran- 
scription start site, is highly homologous to the ISRE con- 
sensus sequence. 
gp96 is a major component of the endoplasmic reticulum 
(27, 28) and has been suggested to be an accessory to antigen 
presentation by MHC class I molecules (26,  29): it accepts 
Peptides transported into the lumen of the endoplasmic retic- 
ulum by transport-associated proteins (TAP) (30) and transfers 
Figure 5.  ATPase  activity in extract of IFN-treated  cells. Daudi cells 
were treated in the absence or presence of IFN-~ (300 IU/mL) and ex- 
tracts were prepared for ATl~se assays as described in the Materials and 
Methods.  ATl~se assays were performed  on samples containing no cell 
extract (lanes 1-3), extract from untreated cells (lanes 4-6) or extract from 
IFN-c~-treated cells (lanes 7-9). Samples were preincubated with no anti- 
body (lanes I, 4, and 7), anti-gp96 antibody (lanes 2, 5, and 8) or normal 
rat IgG (lanes 3, 6, and 9), as described in the Materials and Methods. 
them to MHC class I molecules in an ATP-dependent  manner 
(31). This suggestion is supported by the following observa- 
tions: (a) gp96 is found assodated with a wide array of cel- 
lular Peptides (12 and our unpublished observations); (b) gp96 
possesses Walker A and B consensus sequences, binds ATP 
in vitro and in vivo and is an ATPase (12), permitting a mech- 
anism for active acceptance and transfer of Peptides; (c) gp96 
associates with  the MHC  class I  molecules and  the  cal- 
nexin/p88 molecule (Srivastava, P. K., manuscript submitted 
for publication); (d) immunization of mice with gp96 ob- 
tained from a particular tumor or virus-infected cell elicits 
antigen-specific  T  cell responses against that particular cell 
type, although gp96 sequences, per se, show no polymor- 
phism (32). It is also interesting to note that all of the mole- 
cuhs known so far to be involved in antigen presentation 
by MHC class I have been shown to be upregulated by IFN. 
This includes selected subunits of the proteasome (33),  the 
peptide transporters (34), and the MHC class I molecule it- 
self (35). Our demonstration that gp96 is upregulated in the 
same manner, in conjuction with its other properties, puts 
it squarely in the pathway of antigen presentation. Increase 
of body temperature (heat shock) and release of IFNs are 
among the earliest and the most universal responses to infec- 
tion and it appears reasonable that a molecule that possibly 
plays a key accessory role in antigen presentation (and hence 
in combatting viral infections) is upregulated by both beat 
shock and IFNs. 
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